Log in or Sign up for Free to view tailored content for your specialty!
Allergy/Asthma News
Professor receives NIH research grant to study work-related asthma risks among nurses
A researcher from the University of Arizona Mel and Enid Zuckerman College of Public Health received a $750,000 NIH grant to study the asthma risks associated with cleaning and disinfecting agents commonly used by nurses.
Program to train underrepresented investigators for health equity research
As health systems struggle to improve outcomes in underserved populations, they are turning to scientists and physician-scientists who represent these communities. Yet these scientists also need support as they embark on their careers.
Log in or Sign up for Free to view tailored content for your specialty!
Allergy & Asthma Network says $35 inhaler price cap will improve health, wellness
After three major pharmaceutical companies said they will enact a monthly $35 price cap on their inhaler products, the Allergy & Asthma Network applauded this move to make treatment more affordable for patients.
Database offers local information about asthma prevalence, confounding factors
Approximately 25 million people in the United States — or 7% of the population — has asthma, the Allergy & Asthma Network reports. But that prevalence is not evenly distributed, with wide variation from state to state and even city to city.
Dupilumab lowers type 2 airway inflammation, mucus plugs in uncontrolled asthma
WASHINGTON — Among adults with uncontrolled moderate to severe asthma and high type 2 inflammation measures, 24-week dupilumab lowered inflammation and mucus plug scores, according to study results.
Cincinnati Children’s receives NIH grant to become CoFAR clinical research center
Cincinnati Children’s Hospital Medical Center has been selected as a recipient of an NIH grant to join the Consortium of Food Allergy Research as a clinical research center.
Incyte, CMS enter license agreement to develop, commercialize povorcitinib in Asia
Incyte has entered into a collaboration and license agreement with China Medical System Holdings Limited for the development and commercialization of povorcitinib, the companies announced in a press release.
Top news of March: Oral allergy syndrome, lockdown babies, food allergy treatment
Healio has compiled March’s most-read news in asthma and allergy.
Three important financial tactics to consider when approaching or in retirement
The number one financial goal for most physicians is getting to a comfortable retirement on their own timeline and with the lifestyle they want.
EPA finalizes greenhouse gas emission standards for heavy-duty vehicles
The U.S. Environmental Protection Agency has finalized stricter greenhouse gas emission limits for model year 2027 through 2032 heavy-duty vehicles, according to an agency press release.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read